These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 4189655

  • 1. [Correlation between the protein-bound iodine and butanol-extracted iodine in the blood serum of patients with diffuse toxic goiter during treatment with mercazolyl].
    Okulov VB.
    Probl Endokrinol (Mosk); 1969; 15(4):5-8. PubMed ID: 4189655
    [No Abstract] [Full Text] [Related]

  • 2. [Dynamics of protein-bound iodine and iodine extracted with butanol in diffuse toxic goiter patients treated with radioactive iodine (I-131) after preliminary treatment with mercazolyl and reserpine].
    Anestiadi ZG.
    Probl Endokrinol (Mosk); 1969; 15(1):6-10. PubMed ID: 4185484
    [No Abstract] [Full Text] [Related]

  • 3. [Recurrence rate following thyrostatic therapy of patients with hyperthyroidism and diffuse goiter (Graves' disease). Relation to the concentration of inorganic iodine in the plasma].
    Hansen PE.
    Ugeskr Laeger; 1983 Mar 28; 145(13):980-2. PubMed ID: 6190284
    [No Abstract] [Full Text] [Related]

  • 4. [Dynamics of PBI behavior in blood serum of patients with Graves-Basedow disease and toxic nodular goiter during treatment with methimetazole].
    Jaruga-Dolińska E, Zembrzuska Z, Korman E.
    Endokrynol Pol; 1971 Mar 28; 22(6):535-43. PubMed ID: 4110630
    [No Abstract] [Full Text] [Related]

  • 5. Treatment of thyrotoxicosis with lithium carbonate.
    Lazarus JH, Richards AR, Addison GM, Owen GM.
    Lancet; 1974 Nov 16; 2(7890):1160-3. PubMed ID: 4139588
    [No Abstract] [Full Text] [Related]

  • 6. [Diagnosis and therapy of hyperthyroidism].
    Schwarz K, Scriba PC.
    Med Klin; 1969 Mar 14; 64(11):469-78. PubMed ID: 4181203
    [No Abstract] [Full Text] [Related]

  • 7. [Clinical aspects, diagnosis and drug therapy of hyperthyroidism].
    Bürgi U, Gerber H, Peter HJ.
    Schweiz Med Wochenschr; 1995 Aug 08; 125(31-32):1489-94. PubMed ID: 7545825
    [Abstract] [Full Text] [Related]

  • 8. [The inhibition test of thyroid function with triiodothyronine in hyperthyroid patients under medical therapy: comparison of the values obtained from measures of "early" uptake and in the organic phase].
    Valentini F, Reschini E, Lodeserto A, Vivarelli S, Miedico D.
    Folia Endocrinol; 1968 Aug 08; 21(4):396-403. PubMed ID: 4185869
    [No Abstract] [Full Text] [Related]

  • 9. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
    Roti E, Gardini E, Minelli R, Bianconi L, Salvi M, Gavaruzzi G, Braverman LE.
    J Clin Endocrinol Metab; 1993 Apr 08; 76(4):928-32. PubMed ID: 7682562
    [Abstract] [Full Text] [Related]

  • 10. [Osteocalcin in diffuse toxic goiter].
    Balabolkin MI, Khaiutina TL, Mkrtumian AM.
    Ross Med Zh; 1992 Apr 08; (1):13-5. PubMed ID: 1377070
    [Abstract] [Full Text] [Related]

  • 11. [On the residual thyroid tissue after thyroidectomy for diffuse goiter with thyrotoxicosis].
    Angelescu E, Stoenescu D, Damian A, Taşcă C.
    Stud Cercet Endocrinol; 1973 Apr 08; 24(6):465-71. PubMed ID: 4129363
    [No Abstract] [Full Text] [Related]

  • 12. A randomized trial evaluating a block-replacement regimen during radioiodine therapy.
    Bonnema SJ, Grupe P, Boel-Jørgensen H, Brix TH, Hegedüs L.
    Eur J Clin Invest; 2011 Jul 08; 41(7):693-702. PubMed ID: 21175612
    [Abstract] [Full Text] [Related]

  • 13. [Criteria for recovery from diffuse toxic goiter].
    Baranov VG, Nikolaenko NF.
    Klin Med (Mosk); 1970 Apr 08; 48(4):50-3. PubMed ID: 4193305
    [No Abstract] [Full Text] [Related]

  • 14. [Treatment of diffuse toxic goiter with radioactive iodine in combination with prolonged antithyroid therapy].
    Khramtsova VIa, Potin VV, Shliakhtina LG.
    Probl Endokrinol (Mosk); 1977 Apr 08; 23(2):48-51. PubMed ID: 71726
    [Abstract] [Full Text] [Related]

  • 15. [The treatment of hyperthyroid syndromes. I. Specific therapy. (Clinico-statistical contribution)].
    Donati GS, Guagliano G, Scotti-Foglieni C, Cortinovis R, Pedroni G, Molteni F.
    Chir Ital; 1967 Dec 08; 19(6):957-1106. PubMed ID: 4180460
    [No Abstract] [Full Text] [Related]

  • 16. Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.
    Bogazzi F, Giovannetti C, Fessehatsion R, Tanda ML, Campomori A, Compri E, Rossi G, Ceccarelli C, Vitti P, Pinchera A, Bartalena L, Martino E.
    J Clin Endocrinol Metab; 2010 Jan 08; 95(1):201-8. PubMed ID: 19906789
    [Abstract] [Full Text] [Related]

  • 17. Sensitive thyrotropin and thyrotropin-receptor antibody determinations one month after discontinuation of antithyroid drug treatment as predictors of relapse in Graves' disease.
    Quadbeck B, Hoermann R, Roggenbuck U, Hahn S, Mann K, Janssen OE, Basedow Study Group.
    Thyroid; 2005 Sep 08; 15(9):1047-54. PubMed ID: 16187913
    [Abstract] [Full Text] [Related]

  • 18. [Hyperthyroidism].
    Bürgi U, Maurer P.
    Schweiz Rundsch Med Prax; 1994 Jan 18; 83(3):61-4. PubMed ID: 7507596
    [Abstract] [Full Text] [Related]

  • 19. [Thyroid function and the state of the hypothalamus-hypophysis-thyroid in patients with diffuse toxic goiter after treatment].
    Aliakparova ASh.
    Sov Med; 1973 Dec 18; 36(12):45-8. PubMed ID: 4130665
    [No Abstract] [Full Text] [Related]

  • 20. [Effect of different doses of reserpine on thyroid function and on the effect of mercazolyl in the treatment of diffuse toxic goiter].
    Komarovskaia RP.
    Sov Med; 1970 Nov 18; 33(11):114-7. PubMed ID: 4107499
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.